Ecolab (ECL) said Wednesday it has opened a new facility in King of Prussia, Pennsylvania, to assist biopharmaceutical companies and contract manufacturers with applications and process development of therapeutic molecules.
The site offers process development tools and chromatography columns for drug developers from the early stage of development to commercialization, the company said.
Ecolab said the lab is intended to help clients cut costs, streamline production, and prepare documentation for regulatory submission.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。